EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stock Under $10 that he thinks could potentially double or triple in the next 6 to 12-months. See what he's trading today with a 14-day FREE pass.

Reprint Email

TheStreet Wire

Laboratory Corporation Of America Hldgs (LH): Today's Featured Health Care Winner

By TheStreet Wire 10/25/11 - 05:05 PM EDT

Find out if (LH) is in Cramer's Portfolio.

The health care sector closed the day down 2%. LCA-Vision Inc (LCAV), CEL-SCI Corporation (CVM), World Heart Corporation (WHRT), and China Biologic Products Inc (CBPO) were all winners today within the health care sector with Laboratory Corporation of America Hldgs (LH) being today's featured health care winner. Laboratory Corporation of America Hldgs rose $1 (1.2%) to $84.07 on average volume. Throughout the day, 1.6 million shares of Laboratory Corporation of America Hldgs exchanged hands as compared to its average daily volume of 1.1 million shares.

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company in the United States. Laboratory Corporation of America Hldgs has a market cap of $8.3 billion and is part of the health services industry. The company has a P/E ratio of 14.8, below the average health services industry P/E ratio of 16.5 and below the S&P 500 P/E ratio of 17.7. Shares are down 6.5% year to date as of the close of trading on Monday.

TheStreet Ratings rates Laboratory Corporation of America Hldgs as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, expanding profit margins and good cash flow from operations. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

You can view the full Laboratory Corporation of America Hldgs Ratings Report.

On the negative front, Healthways Inc (HWAY), Tibet Pharmaceuticals Inc (TBET), CHINA NUOKANG BIO-PHARMACEUTICAL Inc (NKBP), and Momenta Pharmaceuticals Inc (MNTA) were all losers within the health care sector with Valeant Pharmaceuticals International Inc (VRX) being today's health care sector Loser Spotlight stock.

Use our health care section to find sector-relevant news.
Or find some new ideas from our top rated stocks lists.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR (XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care (RXD).

Find other investment ideas from our top rated ETFs lists.

For more information on Laboratory Corporation of America Holdings click any of the following:

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:

$2.5+ million portfolio
Large-cap and dividend focus
Intraday trade alerts from Cramer
Weekly roundups

Dividend Stock Advisor

TRY IT FREE

New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:

Diversified model portfolio of dividend stocks
Alerts when market news affect the portfolio
Bi-weekly updates with exact steps to take - BUY, HOLD, SELL

Stocks Under $10

TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:

Model portfolio
Stocks trading below $10
Intraday trade alerts
Weekly roundups

Real Money

TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:

Jim Cramer + 20 Wall Street pros
Intraday commentary & news
Real-time trading forum
Actionable trade ideas

Real Money Pro

TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:

Real Money + Doug Kass + 15 more Wall Street Pros
Intraday commentary & news
Ultra-actionable trading ideas

Options Profits

TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.